FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

8941001000001100: Not available (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40299001000001111 Not available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40299101000001112 Not available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Not available Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Enfamil AR powder (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Doxycycline 100mg tablets (Ennogen Pharma Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
LQD spray (Brancaster Pharma Ltd) 12 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Enfamil AR powder (Reckitt Benckiser Healthcare (UK) Ltd) 400 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
LQD spray (Brancaster Pharma Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Biopolymer wound dressing 12 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Doxycycline 100mg tablets 10 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Enfamil AR powder 400 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Doxycycline 100mg tablets (Ennogen Pharma Ltd) 10 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) 5 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials 5 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Teva UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Lepicol powder 5g sachets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Metoclopramide 100mg/20ml solution for injection ampoules VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Lepicol Lighter powder 3g sachets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Itraconazole 250mg/25ml solution for infusion ampoules and diluent VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Metoclopramide 100mg/20ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Maxolon High Dose 100mg/20ml solution for injection ampoules (Shire Pharmaceuticals Ltd) 10 ampoule 10 x 20ml ampoules VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Sporanox I.V. 250mg/25ml solution for injection ampoules and diluent (Janssen-Cilag Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Generic Lepicol powder 5g sachets 14 sachet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Maxolon High Dose 100mg/20ml solution for injection ampoules (Shire Pharmaceuticals Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Sporanox I.V. 250mg/25ml solution for injection ampoules and diluent (Janssen-Cilag Ltd) 1 ampoule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Itraconazole 250mg/25ml solution for injection ampoules and diluent 1 ampoule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Lepicol Lighter powder 3g sachets (ADM Protexin Ltd) 30 sachet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Lepicol Lighter powder 3g sachets (ADM Protexin Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Lepicol powder 5g sachets (ADM Protexin Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Lepicol Lighter powder 3g sachets 30 sachet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Lepicol powder 5g sachets (ADM Protexin Ltd) 14 sachet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Hepatitis A vaccine (inactivated, adsorbed) suspension for injection 1ml vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Havrix Monodose vaccine suspension for injection 1ml vials (GlaxoSmithKline UK Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Hepatitis A vaccine (inactivated, adsorbed) suspension for injection 1ml vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Telavancin 750mg powder for solution for infusion vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vibativ 750mg powder for solution for infusion vials (Clinigen Healthcare Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
VAQTA Adult vaccine suspension for injection 1ml vials (Organon Pharma (UK) Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
VAQTA Adult vaccine suspension for injection 1ml vials (Organon Pharma (UK) Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Havrix Monodose vaccine suspension for injection 1ml vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vibativ 750mg powder for solution for infusion vials (Clinigen Healthcare Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile and silicone adhesive border 7.5cm x 8cm VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Generic Glytactin Restore Lite 10 oral powder 19g sachets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely dithranol 20 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Necitumumab 800mg/50ml solution for infusion vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Glytactin Restore Lite 10 oral powder 19g sachets 30 sachet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Originalis B.V.) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile and silicone adhesive border 7.5cm x 8cm 1 dressing VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Dithrocream 2% cream (Dermal Laboratories Ltd) 50 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Dithrocream 2% cream (Dermal Laboratories Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Suprasorb P sensitive border dressing 7.5cm x 8cm (L&R Medical UK Ltd) 10 dressing VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Glytactin Restore Lite 10 oral powder 19g sachets (Cambrooke UK Ltd) 30 sachet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Necitumumab 800mg/50ml solution for infusion vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Glytactin Restore Lite 10 oral powder 19g sachets (Cambrooke UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Suprasorb P sensitive border dressing 7.5cm x 8cm (L&R Medical UK Ltd) 1 dressing VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile and silicone adhesive border 7.5cm x 8cm 10 dressing VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Dithranol 2% cream 50 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Suprasorb P sensitive border dressing 7.5cm x 8cm (L&R Medical UK Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cerivastatin sodium 800 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amprenavir 150 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely estradiol hemihydrate 150 microgram/1 actuation conventional release nasal spray (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Zoledronic acid 4mg powder and solvent for infusion vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 2 milligram/1 each conventional release sublingual tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely bifonazole 10 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Aluminum hydroxide oral suspension BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Aromatic magnesium carbonate mixture BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely aluminium hydroxide 600 milligram and magnesium hydroxide 300 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely dried aluminium hydroxide gel 120 milligram/1 milliliter and magnesium hydroxide 60 milligram/1 milliliter conventional release oral suspension (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely alverine citrate 5 milligram/1 gram and Sterculia gum 620 milligram/1 gram conventional release oral granules VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely mebeverine hydrochloride 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cimetidine 400 milligram/1 each conventional release effervescent oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nizatidine 25mg/mL injection solution 4mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ranitidine bismuth citrate 400 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Codeine phosphate+kaolin 10mg/3g/10mL mixture VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Sulfasalazine 3g/100mL retention enema VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ispaghula husk 6g/sachet s/f powder VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Senna 7.5mg/5mL syrup VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sodium acid phosphate 1.72g suppository VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely polythiazide 1 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Bumetanide+potassium 500mcg/7.7Mmol m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Bretylium tosylate 50mg/mL injection solution 10mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Disopyramide 250mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Disopyramide 150mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Mexiletine hydrochloride 360mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely betaxolol hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely nadolol 40 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Metoprolol tartrate+hydrochlorothiazide 200mg/25mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier

Start Previous Page 71 of 304 Next End


This concept is not in any reference sets

Back to Start